Email:

What We Offer

Propargyl-PEG3-acid | CAS 1347760-82-0

Name: Propargyl-PEG3-acid
Brand: BOC Sciences
Rating: 5 (1 reviews)

Inquiry

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Product Introduction

Synonyms	3-(2-(2-(Prop-2-yn-1-yloxy)ethoxy)ethoxy)propanoic acid; Propyne-PEG2-CH2CH2COOH; Alkyne-PEG3-COOH; Propargyl-PEG3-COOH; Propargyl-PEG3-Carboxylic Acid; 3-[2-[2-(2-Propyn-1-yloxy)ethoxy]ethoxy]propanoic acid; Propanoic acid, 3-[2-[2-(2-propyn-1-yloxy)ethoxy]ethoxy]-
Purity	>98.0%
Shelf Life	≥ 2 years
IUPAC Name	3-[2-(2-prop-2-ynoxyethoxy)ethoxy]propanoic acid
Canonical SMILES	C#CCOCCOCCOCCC(=O)O
InChI	InChI=1S/C10H16O5/c1-2-4-13-6-8-15-9-7-14-5-3-10(11)12/h1H,3-9H2,(H,11,12)
InChIKey	CJNSWLAJTZVSRB-UHFFFAOYSA-N
Solubility	Soluble in DCM, DMF, DMSO, Water
Density	1.1±0.1 g/cm3
Appearance	Light yellow to brown clear liquid
Boiling Point	348.0±32.0 °C at 760 mmHg
Vapor Pressure	0.0±1.6 mmHg at 25°C
LogP	-0.44

Storage	Store at -20°C, keep in dry and avoid sunlight
Signal	Warning
GHSHazardStatements	H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
Precautionary Statement Codes	P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364

XLogP3	-0.6
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	10
Exact Mass	216.09977361 g/mol
Monoisotopic Mass	216.09977361 g/mol
Topological Polar Surface Area	65Å²
Heavy Atom Count	15
Formal Charge	0
Complexity	205
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently-Bonded Unit Count	1
Compound Is Canonicalized	Yes

Publication Number	Title	Priority Date
TW-201800110-A	Antibody-drug conjugate based on eribulin and method of use	2016-03-02
US-2017252458-A1	Eribulin-based antibody-drug conjugates and methods of use	2016-03-02
US-2018193478-A1	Eribulin-based antibody-drug conjugates and methods of use	2016-03-02
US-2017114341-A1	Polynucleotide constructs having bioreversible and non-bioreversible groups	2014-06-06
US-2020392498-A1	Polynucleotide constructs having bioreversible and non-bioreversible groups	2014-06-06